当前位置：
X-MOL 学术
›
Protein Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignances.
Protein & Cell ( IF 13.6 ) Pub Date : 2024-06-01 , DOI: 10.1093/procel/pwae034 Lijun Zhao 1 , Shuhong Li 1 , Xiaoyi Wei 1 , Xuexiu Qi 1 , Qiaoru Guo 1 , Licai Shi 1 , Ji-Shuai Zhang 2 , Jun Li 3 , Ze-Lin Liu 4 , Zhi Guo 4 , Hongyu Zhang 5 , Jia Feng 5 , Yuanyuan Shi 6 , Suping Zhang 7 , Yu J Cao 1, 8
中文翻译：
一种新型基于环结构的双特异性 CAR，靶向 CD19 和 CD22，可增强对 B 细胞恶性肿瘤的治疗功效。
更新日期：2024-06-01
Protein & Cell ( IF 13.6 ) Pub Date : 2024-06-01 , DOI: 10.1093/procel/pwae034 Lijun Zhao 1 , Shuhong Li 1 , Xiaoyi Wei 1 , Xuexiu Qi 1 , Qiaoru Guo 1 , Licai Shi 1 , Ji-Shuai Zhang 2 , Jun Li 3 , Ze-Lin Liu 4 , Zhi Guo 4 , Hongyu Zhang 5 , Jia Feng 5 , Yuanyuan Shi 6 , Suping Zhang 7 , Yu J Cao 1, 8
Affiliation
中文翻译：
一种新型基于环结构的双特异性 CAR，靶向 CD19 和 CD22，可增强对 B 细胞恶性肿瘤的治疗功效。
京公网安备 11010802027423号